Danon Disease-Associated LAMP-2 Deficiency Drives Metabolic Signature Indicative of Mitochondrial Aging and Fibrosis in Cardiac Tissue and hiPSC-Derived Cardiomyocytes
- Supplementary File 1:
ZIP-Document (ZIP, 2645 KiB)
Del Favero, G.; Bonifacio, A.; Rowland, T.J.; Gao, S.; Song, K.; Sergo, V.; Adler, E.D.; Mestroni, L.; Sbaizero, O.; Taylor, M.R.G. Danon Disease-Associated LAMP-2 Deficiency Drives Metabolic Signature Indicative of Mitochondrial Aging and Fibrosis in Cardiac Tissue and hiPSC-Derived Cardiomyocytes. J. Clin. Med. 2020, 9, 2457. https://doi.org/10.3390/jcm9082457
Del Favero G, Bonifacio A, Rowland TJ, Gao S, Song K, Sergo V, Adler ED, Mestroni L, Sbaizero O, Taylor MRG. Danon Disease-Associated LAMP-2 Deficiency Drives Metabolic Signature Indicative of Mitochondrial Aging and Fibrosis in Cardiac Tissue and hiPSC-Derived Cardiomyocytes. Journal of Clinical Medicine. 2020; 9(8):2457. https://doi.org/10.3390/jcm9082457
Chicago/Turabian StyleDel Favero, Giorgia; Bonifacio, Alois; Rowland, Teisha J.; Gao, Shanshan; Song, Kunhua; Sergo, Valter; Adler, Eric D.; Mestroni, Luisa; Sbaizero, Orfeo; Taylor, Matthew R.G. 2020. "Danon Disease-Associated LAMP-2 Deficiency Drives Metabolic Signature Indicative of Mitochondrial Aging and Fibrosis in Cardiac Tissue and hiPSC-Derived Cardiomyocytes" J. Clin. Med. 9, no. 8: 2457. https://doi.org/10.3390/jcm9082457